#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute leukaemia Behcet's syndrome Lymphoma Epstein-Barr virus infection Deafness neurosensory Hepatitis D Chronic graft versus host disease in skin Leber's congenital amaurosis Hypergammaglobulinaemia benign monoclonal Ependymoma Oesophageal adenocarcinoma Haemophilia A without inhibitors Endocrine ophthalmopathy Chondrosarcoma Conjunctivitis allergic More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Treatment Immunodeficiency congenital – Life with Disease Haemophagocytic lymphohistiocytosis Malignant fibrous histiocytoma – Diagnostics Paraneoplastic neurological syndrome – Trials in Disease Idiopathic pulmonary fibrosis Noonan syndrome Hairy cell leukaemia – Treatment Anaplastic thyroid cancer – Treatment Pemphigoid – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TORASEMIDE Gskvx000000017033 Rbd4059 Bisoprolol Ivacaftor Xp-Dc+Tl+Klh Etamsylate Levocabastine Hydrochloride Talquetamab Cedazuridine Alpelisib Omo-103 Zoledronic Acid Trastuzumab Tazemetostat Cabazitaxel Granisetron Gilteritinib [18F] CANAGLIFLOZIN Amifostine Thiol More therapies…

    Learn about Your Condition

    Osteoporosis Radicular pain Leukocyte adhesion deficiency Breast angiosarcoma metastatic Plasma cell myeloma recurrent Guttate psoriasis Rhabdoid tumour of the kidney Peripheral artery angioplasty Colon cancer stage III Neurotrophic keratopathy Precocious puberty Endocrine disorder Pulmonary resection Myotonia Gastrooesophageal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Belgium Czechia Denmark France Germany Hungary +5

  • Study on Dexamethasone and Olanzapine for Patients Undergoing Heart Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Dexamethasone Disodium Phosphate
    • Placebo
    • Olanzapine
    Denmark

  • Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Docetaxel
    • Humanised Igg1 Monoclonal Antibody Against Cd152
    Belgium Germany Italy The Netherlands Spain

  • Study on Estrogen Treatment (Oral vs. Transdermal) for Women with Turner Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Turner’s syndrome
    Investigated Drugs:
    • Estradiol
    Denmark

  • A study comparing azithromycin with cefuroxime versus cefuroxime alone for preventing infections in patients undergoing hysterectomy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hysterectomy
    Investigated Drugs:
    • Azithromycin
    Finland

  • Study on Glioblastoma Treatment with Metformin, Temozolomide, and Radiotherapy for Newly Diagnosed Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    • Glioblastoma
    Investigated Drugs:
    • Metformin Hydrochloride
    • Temozolomide
    France
Previous Page
1 … 624 625 626 627 628 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!